Absci (ABSI) Share-based Compensation (2020 - 2026)

Absci's (ABSI) quarterly Share-based Compensation came in at $4.4 million in Q1 2026, down 10.85% year-on-year from $4.9 million in Q1 2025, and up 2.89% quarter-over-quarter from $4.3 million in Q4 2025.

Absci (ABSI) Share-based Compensation (2020 - 2026) Analysis & Trends

Absci has disclosed Share-based Compensation across 7 years of filings, most recently posting $4.4 million for Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $4.4 million, down 10.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.8 million (down 14.38% YoY), and the FY2025 annual result was $18.3 million, down 5.81% from the prior year.
  • Share-based Compensation came in at $4.4 million for Q1 2026 at Absci, up from $4.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $5.5 million in Q3 2024 to a low of $1.0 million in Q4 2022.
  • The 5-year median for Share-based Compensation is $4.2 million (2022), against an average of $3.9 million.
  • Across the five-year window, Share-based Compensation slumped 68.32% in 2022 and surged 210.45% in 2023, its largest moves.
  • Absci's Share-based Compensation stood at $1.0 million in 2022, then soared by 210.45% to $3.2 million in 2023, then surged by 59.42% to $5.1 million in 2024, then declined by 16.0% to $4.3 million in 2025, then grew by 2.89% to $4.4 million in 2026.
  • The last three Share-based Compensation figures came in at $4.4 million (Q1 2026), $4.3 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Absci 1.13 Bn 1.01 Bn - 4.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.38 Mn
Mar 31, 2026 4.38 Mn
Dec 31, 2025 4.26 Mn
Dec 31, 2025 4.26 Mn
Sep 30, 2025 4.40 Mn
Sep 30, 2025 4.40 Mn
Jun 30, 2025 4.75 Mn
Jun 30, 2025 4.75 Mn
Mar 31, 2025 4.91 Mn
Mar 31, 2025 4.91 Mn
Dec 31, 2024 5.07 Mn
Dec 31, 2024 5.07 Mn
Sep 30, 2024 5.51 Mn
Sep 30, 2024 5.51 Mn
Jun 30, 2024 5.29 Mn
Jun 30, 2024 5.29 Mn
Mar 31, 2024 3.59 Mn
Mar 31, 2024 3.59 Mn
Dec 31, 2023 3.18 Mn
Dec 31, 2023 3.18 Mn